James Grant Warner Jr, MD - Medicare Cardiovascular Disease (cardiology) in Lynchburg, VA

James Grant Warner Jr, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Lynchburg, Virginia. He went to West Virginia University School Of Medicine and graduated in 1989 and has 35 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). He is a member of the group practice Centra Medical Group Llc and his current practice location is 2410 Atherholt Rd, Lynchburg, Virginia. You can reach out to his office (for appointments etc.) via phone at (434) 200-5252.

James Grant Warner Jr is licensed to practice in Virginia (license number 0101059334) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1184680092.

Contact Information

James Grant Warner Jr, MD
2410 Atherholt Rd,
Lynchburg, VA 24501-2148
(434) 200-5252
Not Available



Physician's Profile

Full NameJames Grant Warner Jr
GenderMale
SpecialityCardiovascular Disease (cardiology)
Experience35 Years
Location2410 Atherholt Rd, Lynchburg, Virginia
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • James Grant Warner Jr attended and graduated from West Virginia University School Of Medicine in 1989
  NPI Data:
  • NPI Number: 1184680092
  • Provider Enumeration Date: 04/21/2006
  • Last Update Date: 04/01/2014
  Medicare PECOS Information:
  • PECOS PAC ID: 9234227844
  • Enrollment ID: I20080508000225

Medical Identifiers

Medical identifiers for James Grant Warner Jr such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184680092NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RC0000XInternal Medicine - Cardiovascular Disease 0101059334 (Virginia)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Centra Health - Lynchburg Gen HospitalLynchburg, VAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Centra Medical Group Llc4789606088603

News Archive

Potential covalent SARS-CoV-2 spike protein inhibitors

There remains a significant need for new and effective drugs that can be used to treat COVID-19.

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

Breast cancer survivor supports patients and survivors of breast cancer

Barbara Feigin, successful business owner and breast cancer survivor, wanted to find a unique and memorable way to honor other breast cancer survivors and those who have fallen to the disease so she decided to paint the 44,000 square-foot administrative building at her company MainStreet America pink.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James Grant Warner Jr allows following entities to bill medicare on his behalf.
Entity NameCentra Medical Group Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649228966
PECOS PAC ID: 4789606088
Enrollment ID: O20051230000147

News Archive

Potential covalent SARS-CoV-2 spike protein inhibitors

There remains a significant need for new and effective drugs that can be used to treat COVID-19.

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

Breast cancer survivor supports patients and survivors of breast cancer

Barbara Feigin, successful business owner and breast cancer survivor, wanted to find a unique and memorable way to honor other breast cancer survivors and those who have fallen to the disease so she decided to paint the 44,000 square-foot administrative building at her company MainStreet America pink.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Read more Medical News

› Verified 6 days ago

Entity NameCentra Health, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770693939
PECOS PAC ID: 6002719713
Enrollment ID: O20191218000107

News Archive

Potential covalent SARS-CoV-2 spike protein inhibitors

There remains a significant need for new and effective drugs that can be used to treat COVID-19.

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

Breast cancer survivor supports patients and survivors of breast cancer

Barbara Feigin, successful business owner and breast cancer survivor, wanted to find a unique and memorable way to honor other breast cancer survivors and those who have fallen to the disease so she decided to paint the 44,000 square-foot administrative building at her company MainStreet America pink.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Grant Warner Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
James Grant Warner Jr, MD
1204 Fenwick Dr,
Lynchburg, VA 24502-2112

Ph: () -
James Grant Warner Jr, MD
2410 Atherholt Rd,
Lynchburg, VA 24501-2148

Ph: (434) 200-5252

News Archive

Potential covalent SARS-CoV-2 spike protein inhibitors

There remains a significant need for new and effective drugs that can be used to treat COVID-19.

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

Breast cancer survivor supports patients and survivors of breast cancer

Barbara Feigin, successful business owner and breast cancer survivor, wanted to find a unique and memorable way to honor other breast cancer survivors and those who have fallen to the disease so she decided to paint the 44,000 square-foot administrative building at her company MainStreet America pink.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Novartis announced today that the European Commission approved once-daily Ultibro® Breezhaler® (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). In addition, the Japanese Ministry of Health, Labour and Welfare (MHLW) approved once-daily Ultibro® Inhalation Capsules (glycopyrronium 50 mcg / indacaterol 110 mcg), delivered through the Breezhaler® device, for relief of various symptoms due to airway obstruction in chronic obstructive pulmonary disease (COPD). Ultibro® Breezhaler® / Ultibro® Inhalation Capsules were developed under the name QVA149.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Lynchburg, VA

Varsha Reddy Pothula Venkata, MD
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 103 Clifton St, Lynchburg, VA 24501
Phone: 434-455-7100    Fax: 434-947-5909
Dr. James D Cure, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1901 Thomson Dr, Lynchburg, VA 24501
Phone: 434-947-3908    Fax: 434-947-5948
Edward Vincent Bonyak, MD
Cardiovascular Disease
Medicare: May Accept Medicare Assignments
Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501
Phone: 434-200-5252    Fax: 434-200-5252
Sally- Ann Tracy Mcintosh, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2215 Landover Pl, Lynchburg, VA 24501
Phone: 434-947-3944    Fax: 866-617-8273
Dr. John Newton Clore, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 125 Nationwide Dr, Internal Medicine, Lynchburg, VA 24502
Phone: 434-200-3908    
Dr. Evan D. Ownby, MD
Cardiovascular Disease
Medicare: May Accept Medicare Assignments
Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501
Phone: 434-200-2712    Fax: 434-200-2851
Dr. Samuel Omotoye, M.D., FRCPC
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501
Phone: 434-200-2712    Fax: 434-200-2851

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.